Abacavir

Results: 211



#Item
151Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
152020977s019 Abacavir Clinical PREA

020977s019 Abacavir Clinical PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
153Urgent Need to Develop and Deliver Antiretroviral Treatment Formulations for Infants and Children with HIV/AIDS

Urgent Need to Develop and Deliver Antiretroviral Treatment Formulations for Infants and Children with HIV/AIDS

Add to Reading List

Source URL: www.dndi.org

Language: English - Date: 2013-11-27 08:13:05
154Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
155Microsoft PowerPoint - retrovir slides final HANDOUT - Karesh.ppt

Microsoft PowerPoint - retrovir slides final HANDOUT - Karesh.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English
156Microsoft PowerPoint - Kaletra Neonate HANDOUT- Boxwell.ppt

Microsoft PowerPoint - Kaletra Neonate HANDOUT- Boxwell.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English
157APPENDIX I  THE PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF SOURCES OF FUNDING (Dollars in Millions)

APPENDIX I THE PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF SOURCES OF FUNDING (Dollars in Millions)

Add to Reading List

Source URL: www.pepfar.gov

Language: English - Date: 2014-09-01 00:42:39
158HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZIAGEN safely and effectively. See full prescribing information for ZIAGEN.  

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZIAGEN safely and effectively. See full prescribing information for ZIAGEN. 

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-03-16 16:23:56
159HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FUZEON safely and effectively. See full prescribing information for FUZEON.  •

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FUZEON safely and effectively. See full prescribing information for FUZEON. •

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-04-29 14:25:21
160PIPELINE WATCH  Abacavir arrives at European SPC expiries he end of June 2014 will bring the end of supplementary protection certificate (SPC) exclusivity for the antiretroviral abacavir throughout western Europe, as wel

PIPELINE WATCH Abacavir arrives at European SPC expiries he end of June 2014 will bring the end of supplementary protection certificate (SPC) exclusivity for the antiretroviral abacavir throughout western Europe, as wel

Add to Reading List

Source URL: learnabout.arkpatentintelligence.com

Language: English - Date: 2014-07-30 02:15:45